Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashir, R. M.
Right arrow Articles by Whitaker, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bashir, R. M.
Right arrow Articles by Whitaker, J. N.
NEUROLOGY 1980;30:1184
© 1980 American Academy of Neurology

Metabolism of a peptide of human myeh basic protein in the rabbit

Rifaat M. Bashir, M.D. and John N. Whitaker, M.D.

Neurology and Research Services, Memphis Veterans Administration Medical Center, and the Department of Neurology, University of Tennessee Center for the Health Sciences, Memphis, TN.

Material cross-reactive with myelin basic protein (BP) peptide 43–88 has been identified as a major BP-like antigen appearing in human cerebrospinal fluid during acute myelin injury. In an effort to develop a means for detecting this material in the more accessible body fluids of blood and urine, as well as to determine its metabolic fate, the manner in which rabbits handle human BP peptide 43–88 was investigated. Unlabeled peptide was administered intravenously, and its concentration in plasma was monitored by radioimmunoassay. In studies of 10 rabbits, the peptide disappeared from blood in two phases, the first showing a half-life of 6.0 ± 1.2 minutes and the second a half-life of 51.6 ± 5.4 minutes. Organ-exclusion experiments indicated a rapid clearance, predominantly by the kidney, for the peptide, with tubular reabsorption and cleavage into smaller peptide fragments a probable catabolic mechanism.

Address correspondence and reprint requests to Dr. Whitaker, Neurology Service, Memphis Veterans Administration Medical Center, 1030 Jefferson Avenue, Memphis, TN 38104.

Accepted for publication January 9, 1980.

This work was supported by the Medical Research Service of the Veterans Administration and by Grant No. 1111-A-3 from the National Multiple Sclerosis Society. Dr. Bashir is an Associate Investigator and Dr. Whitaker a Medical Investigator of the Veterans Administration.




This article has been cited by other articles:


Home page
Mult SclerHome page
J. N Whitaker
Myelin basic protein in cerebrospinal fluid and other body fluids
Multiple Sclerosis, February 1, 1998; 4(1): 16 - 21.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.